Presentations at FutureTox V

Organ-specific Toxicology 
May 10-11, 2022 - Chapel Hill, North Carolina, USA

Visit meeting website

ICCVAM Committee Participation

  • Suzanne Fitzpatrick, FDA Center for Food Safety and Applied Nutrition (ICCVAM principal agency representative, FDA) and Donna Mendrick, FDA National Center for Toxicological Research (ICCVAM member, FDA) were members of the conference organizing committee.
  • Donna Mendrick, FDA, was a lead discussant for the following plenary sessions:
    • New Models for Evaluating Effects of Drugs and Chemicals on the Liver
    • New Technologies for Organ Injury for Prediction and Assessment
  • Suzanne Fitzpatrick, FDA, Donna Mendrick, FDA, and Acting NICEATM Director Nicole Kleinstreuer (ICCVAM member, NIEHS) led breakout group discussions at the end of the meeting.

NICEATM Poster Presentations

Fit for Purpose Evaluations of In Vitro Assays for IVIVE
Authors: X Chang, S Bell, J Abedini, D Allen, N Kleinstreuer
View Chang et al poster

Integrating Parameter Uncertainty in PBPK Modeling
D Hines, J Abedini, D Allen, N Kleinstreuer, K Mansouri
View Hines et al poster

Developing In Vitro Assay Annotations to Provide Context and Facilitate Interpretation Toward Toxicological Endpoints
AL Karmaus, P Ceger, J Rooney, S Bell, D Allen, N Kleinstreuer
View Karmaus et al poster